What is Eton Pharmaceuticals, Inc.'s current debt?

Eton Pharmaceuticals, Inc. (ETON) reported current debt of $11.81M in Q1 2026.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s current debt?

Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s current debt has grown at a 59.6% compound annual growth rate (CAGR), from $849K to $8.79M.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Eton Pharmaceuticals, Inc. ETON Current Debt

Current Debt at other companies

ANI PharmaceuticalsANIP

$19.3M+72.4%

PTC TherapeuticsPTCT

$286.94M+5,585%

BioCryst PharmaceuticalsBCRX

$1.24M-31.2%

AMP

Amphastar PharmaceuticalsAMPH

$1.67M+646%

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

See full

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

See full

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

See full

Market cap$930.79M+156%

Enterprise value$942.39M+150%

P/S10.7×+3.2×

Profitability

See full

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

See full

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DebtCurrent.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s current debt?: Eton Pharmaceuticals, Inc. (ETON) reported current debt of $11.81M in Q1 2026.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s current debt?: Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s current debt has grown at a 59.6% compound annual growth rate (CAGR), from $849K to $8.79M.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.